232 related articles for article (PubMed ID: 25230688)
1. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy.
Zhou SW; Zhang M; Zhu M
Mol Med Rep; 2014 Nov; 10(5):2351-7. PubMed ID: 25230688
[TBL] [Abstract][Full Text] [Related]
2. [Sodium nitrite reduces lipid accumulation in steatotic cells by enhancing autophagy].
Zhang YJ; Zheng NR; Liu B; Ji AL; Li YZ; Huangfu CS
Yao Xue Xue Bao; 2015 Aug; 50(8):1000-7. PubMed ID: 26669000
[TBL] [Abstract][Full Text] [Related]
3. [Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy].
Shi YM; Fu ZH; Zhu CS; Li XP
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1770-1778. PubMed ID: 37282951
[TBL] [Abstract][Full Text] [Related]
4. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG
PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.
Chu JH; Wang H; Ye Y; Chan PK; Pan SY; Fong WF; Yu ZL
World J Gastroenterol; 2011 May; 17(19):2379-88. PubMed ID: 21633637
[TBL] [Abstract][Full Text] [Related]
6. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
7. [Liraglutide alleviates lipotoxic liver cell damage and promotes autophagy to improve non-alcoholic fatty liver].
Zhang Q; Liu Q; Niu CY
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):456-461. PubMed ID: 34107584
[No Abstract] [Full Text] [Related]
8. Liraglutide ameliorates hepatic steatosis via retinoic acid receptor-related orphan receptor α-mediated autophagy pathway.
Yu X; Bian X; Zhang H; Yang S; Cui D; Su Z
IUBMB Life; 2023 Oct; 75(10):856-867. PubMed ID: 37310057
[TBL] [Abstract][Full Text] [Related]
9. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
10. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.
Sharma S; Mells JE; Fu PP; Saxena NK; Anania FA
PLoS One; 2011; 6(9):e25269. PubMed ID: 21957486
[TBL] [Abstract][Full Text] [Related]
11. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
[TBL] [Abstract][Full Text] [Related]
12. Hugan Qingzhi medication ameliorates free fatty acid-induced L02 hepatocyte endoplasmic reticulum stress by regulating the activation of PKC-δ.
Yang M; Chen Z; Xiang S; Xia F; Tang W; Yao X; Zhou B
BMC Complement Med Ther; 2020 Dec; 20(1):377. PubMed ID: 33308192
[TBL] [Abstract][Full Text] [Related]
13. Xiaoyao San attenuates hepatic steatosis through estrogen receptor α pathway in ovariectomized ApoE-/- mice.
Hu T; Wei M; Hong G; Qi T; Xiang Y; Yang Y; Yi Y
J Ethnopharmacol; 2022 Jan; 282():114612. PubMed ID: 34496266
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway.
Fang Y; Ji L; Zhu C; Xiao Y; Zhang J; Lu J; Yin J; Wei L
Front Cell Dev Biol; 2020; 8():602574. PubMed ID: 33330497
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy impairs free fatty acid-induced excessive lipid accumulation in hepatocellular carcinoma and hepatic cells.
Chen X; Liu H; Chen K; Guo Y; Mo T; Gao T
J Biosci; 2022; 47():. PubMed ID: 36210729
[TBL] [Abstract][Full Text] [Related]
16.
Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
[No Abstract] [Full Text] [Related]
17. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.
Zheng L; Lv GC; Sheng J; Yang YD
J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876
[TBL] [Abstract][Full Text] [Related]
18. ERp57 is up-regulated in free fatty acids-induced steatotic L-02 cells and human nonalcoholic fatty livers.
Wang H; Chan PK; Pan SY; Kwon KH; Ye Y; Chu JH; Fong WF; Tsui WM; Yu ZL
J Cell Biochem; 2010 Aug; 110(6):1447-56. PubMed ID: 20506389
[TBL] [Abstract][Full Text] [Related]
19. Lipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cells.
Wang JW; Wan XY; Zhu HT; Lu C; Yu WL; Yu CH; Shen Z; Li YM
PLoS One; 2014; 9(4):e96124. PubMed ID: 24788149
[TBL] [Abstract][Full Text] [Related]
20. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway.
Xu N; Luo H; Li M; Wu J; Wu X; Chen L; Gan Y; Guan F; Li M; Su Z; Chen J; Liu Y
Biomed Pharmacother; 2021 Feb; 134():111104. PubMed ID: 33341045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
